Skip to main content

Table 5 Factorial design layout

From: A Design of Experiment (DoE) based approach for development and optimization of nanosuspensions of telmisartan, a BCS class II antihypertensive drug

S No.

Combination

X1 (HPMC E15) (mg)

X2 (SPEED) (rpm)

Particle size (nm)

Cumulative percentage drug release (%)

1

1

0.5

1500

373.3

93.3

2

X1

1

1500

243.9

102.4

3

X2

0.5

2000

339.3

86.6

4

X1X2

1

2000

433.9

100.4

5

midpoint

0.75

1750.0

565.6

90.8

6

midpoint

0.75

1750.0

566.6

91.5

7

midpoint

0.75

1750.0

560.1

92.1

8

midpoint

0.75

1750.0

560.5

90.7